Table 2.
Oncologic outcome for the whole cohort and for patients with thoracic or abdominal tumor location only
Oncologic Outcome | All patients (n = 95) | Patients with thoracic or abdominal tumor location only (n = 65) | ||||
---|---|---|---|---|---|---|
nCRT + S (n = 40) | dCRT (n = 55) | p-value | nCRT + S (n = 36) | dCRT (n = 29) | p-value | |
Overall survival in months (median) | 43.3 | 23.2 | 0.228 | 43.3 | 20.8 | 0.211 |
Progression-free survival in months (median) | 18.3 | 12.7 | 0.108 | 19.3 | 14.0 | 0.115 |
Patterns of treatment failure | ||||||
Local failure, n (%) | 4 (10%) | 21 (38%) | 0.002 | 3 (8%) | 8 (28%) | 0.051 |
Regional failure, n (%) | 9 (23%) | 7 (13%) | 0.269 | 7 (19%) | 3 (10%) | 0.491 |
Distant failure, n (%) | 4 (10%) | 9 (16%) | 0.547 | 3 (8%) | 4 (14%) | 0.691 |